Mon 26 Oct 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
2026-01-16
SFDA Approves Registration of “Anktiva” for the Treatment of Bladder and Lung Cancer
The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva (nogapendekin alfa inbakicept) in combination with immunotherapy...
2026-06-29
SFDA Approves Registration of “Iqirvo” for the Treatment of Primary Biliary Cholangitis
The Saudi Food and Drug Authority (SFDA) has approved the registration of Iqirvo (Elafibranor) for the treatment of adults with primary biliary...
2025-08-24
SFDA Approves Registration of “Tzield” for Delaying Type 1 Diabetes
The Saudi Food and Drug Authority (SFDA) has approved the registration of Tzield (teplizumab) to delay the onset of Stage 3 type 1 diabetes in adults...
2026-05-15
SFDA Approves Registration of New Treatment for Advanced or Metastatic Breast Cancer with a Gene Mut
The Saudi Food and Drug Authority (SFDA) has approved the registration of Etcamah (camizestrant) for the treatment of adult patients with locally...
2025-07-29
SFDA Approves the Registration of “Leqembi” as the First Alzheimer’s Treatment in Saudi Arabia
The Saudi Food and Drug Authority (SFDA) has approved the registration of Leqembi (lecanemab) for the treatment of patients with mild cognitive...
2025-11-10
SFDA Approves the Registration of “Pemazyre” for the Treatment of Bile Duct Cancer in Adults
The Saudi Food and Drug Authority (SFDA) has approved the registration of Pemazyre (Pemigatinib) as a monotherapy for adults with locally advanced or...Last update date: 19/10/2026 at 07:30 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.